Brean Murray Initiates Coverage on Ardea Biosciences (RDEA) with a Buy; Addressing a Clear Need
Tweet Send to a Friend
Brean Murray initiates coverage on Ardea Biosciences (Nasdaq: RDEA) with a Buy. Price target $19.
Brean analyst says, "Plenty ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Brean analyst says, "Plenty ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
